About Genesis Therapeutics
Genesis Therapeutics is a company based in San Francisco (United States) founded in 2019 by Ben Sklaroff, James Schaeffer, and Evan Feinberg.. Genesis Therapeutics has raised $304.02 million across 5 funding rounds from investors including Fidelity Investments, BlackRock and T. Rowe Price. Genesis Therapeutics operates in a competitive market with competitors including Relay Therapeutics, Atomwise, Unnatural Products, neoX Biotech and Celeris Therapeutics, among others.
- Headquarter San Francisco, United States
- Founders Ben Sklaroff, James Schaeffer, Evan Feinberg
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genesis Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$304.02 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Fidelity Investments
& 15 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Genesis Therapeutics
Genesis Therapeutics has successfully raised a total of $304.02M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(21 Nov 2019)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series B - Genesis Therapeutics | Valuation | NVentures |
|
| Aug, 2023 | Amount | Series B - Genesis Therapeutics | Valuation | a16z | |
| Jun, 2022 | Amount | Series A - Genesis Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genesis Therapeutics
Genesis Therapeutics has secured backing from 16 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, BlackRock and T. Rowe Price. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital arm of Nvidia
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on AI-driven companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genesis Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genesis Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genesis Therapeutics Comparisons
Competitors of Genesis Therapeutics
Genesis Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Relay Therapeutics, Atomwise, Unnatural Products, neoX Biotech and Celeris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery platform is developed to study protein motion.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for structure-based drug discovery is provided.
|
|
| domain | founded_year | HQ Location |
Peptides are engineered via computational biology for undruggable targets.
|
|
| domain | founded_year | HQ Location |
Protein-protein interactions are researched and characterized to aid drug discovery.
|
|
| domain | founded_year | HQ Location |
An AI-driven degrader platform for drug discovery is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genesis Therapeutics
Frequently Asked Questions about Genesis Therapeutics
When was Genesis Therapeutics founded?
Genesis Therapeutics was founded in 2019.
Where is Genesis Therapeutics located?
Genesis Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Genesis Therapeutics?
Evan Feinberg is the current CEO of Genesis Therapeutics. They have also founded this company.
Is Genesis Therapeutics a funded company?
Genesis Therapeutics is a funded company, having raised a total of $304.02M across 5 funding rounds to date. The company's 1st funding round was a Series A of $23.89M, raised on Nov 21, 2019.
What does Genesis Therapeutics do?
Genesis Therapeutics was founded in 2019 in San Francisco, United States, within the biotechnology sector. A computational platform is utilized for small molecule drug discovery, incorporating artificial intelligence. Neural networks and biophysical simulations are integrated with a scalable computing infrastructure to support drug design and development. Operations center on enhancing efficiency in pharmaceutical innovation through these methods.
Who are the top competitors of Genesis Therapeutics?
Genesis Therapeutics's top competitors include Atomwise, Unnatural Products and Relay Therapeutics.
Who are Genesis Therapeutics's investors?
Genesis Therapeutics has 16 investors. Key investors include Fidelity Investments, BlackRock, T. Rowe Price, NVentures, and Andreessen Horowitz.